Health Systems, Economic Evaluations, Quality of Life

58 ta ish

1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

   Theo Vos, Stephen S Lim, Cristiana Abbafati +97

   MaqolaGlobal Maternal and Child HealthThe Lancet202012 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.000036

2. Addressing the challenges of improving primary care quality in Uzbekistan: a qualitative study of Chronic Heart Failure management

   Mohir Ahmedov, John Green, Ravshan Azimov +3

   MaqolaHeart Failure Treatment and ManagementHealth Policy and Planning20122 iqtibos

   ABIABI:AkademIndex/openalex/2012.article.000085

3. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement

   Gretchen A Stevens, Leontine Alkema, Robert E. Black +16

   Sharh maqolaHealth Systems, Economic Evaluations, Quality of LifeThe Lancet20162 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.000012

4. GW28-e1018 Study of endpoints in patients with chronic heart failure to determine the prognosis

   U. K. Kamilova, Nuriddin Nuritdinov

   MaqolaDiabetes Management and ResearchJournal of the American College of Cardiology20171 iqtibos

   ABIABI:AkademIndex/openalex/2017.article.000245

5. Positionspapier zur Zertifizierung von Telemedizinzentren

   Thomas M. Helms, Christian Perings, Philipp Sommer +8

   MaqolaClinical practice guidelines implementationDer Kardiologe20211 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.000470

6. National cancer control plans: a global analysis

   Yannick Romero, Dario Trapani, Sonali Johnson +7

   Sharh maqolaGlobal Cancer Incidence and ScreeningThe Lancet Oncology20181 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.000021

7. Core elements of national cancer control plans: a tool to support plan development and review

   Andrew Oar, Fábio Ynoe de Moraes, Yannick Romero +2

   Sharh maqolaGlobal Cancer Incidence and ScreeningThe Lancet Oncology20191 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.000027

8. Enhancing global access to cancer medicines

   Javier Cortés, José Manuel Pérez-García, Antonio Llombart‐Cussac +13

   Sharh maqolaEconomic and Financial Impacts of CancerCA A Cancer Journal for Clinicians20201 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.000031

9. A Status Report on the Health Care Sector in France

   N. Lalitha, Samira Guennif

   MaqolaPharmaceutical Economics and PolicyJournal of Health Management20080 iqtibos

   ABIABI:AkademIndex/openalex/2008.article.000392

10. Efficacy and safety of combined antihypertensive therapy with ramipril and moxonidine in patients with metabolic syndrome

    Jamol Uzokov, Aniskhon Lutfullayevich Alyavi, Ilhom Yunuskhonovich Akhmedov +2

    MaqolaBlood Pressure and Hypertension StudiesJournal of the American Society of Hypertension20160 iqtibos

    ABIABI:AkademIndex/openalex/2016.article.000281

11. TCTAP A-076 Prognosis of Unfavorable Outcomes in Patients with Heart Failure Combined with Diabetes Mellitus

    Mirzo Juraev

    MaqolaCardiovascular Function and Risk FactorsJournal of the American College of Cardiology20160 iqtibos

    ABIABI:AkademIndex/openalex/2016.article.000575

12. Compliance initiatives in management of patients with coronary artery disease and parkinsonism syndrome

    A. Shalaeva, N. Dadabaeva, M. Bozorboev +1

    MaqolaHealth Systems, Economic Evaluations, Quality of LifeAtherosclerosis20160 iqtibos

    ABIABI:AkademIndex/openalex/2016.article.000706

13. GW27-e1256 EFFICACY EVALUATION OF BETA BLOCKERS IN THE PATIENTS WITH CHRONIC HEART FAILURE IN RELATION TO THE STATE OF BETA1-ADRENORECEPTORS

    U. K. Kamilova, Tohirahon Alieva, Kodir Boboev

    MaqolaHormonal Regulation and HypertensionJournal of the American College of Cardiology20160 iqtibos

    ABIABI:AkademIndex/openalex/2016.article.000743

14. TCTAP A-157 Short Term Outcomes After Percutaneous Interventions in Patients with Metabolic Syndrome

    Jamol Uzokov, Anis Alyavi, Bakhrom Alyavi

    MaqolaHealth Systems, Economic Evaluations, Quality of LifeJournal of the American College of Cardiology20170 iqtibos

    ABIABI:AkademIndex/openalex/2017.article.000599

15. Compliance initiatives in management of patients with coronary artery disease after acute myocardial infarction

    A. Shalaeva, N. Dadabaeva

    MaqolaHealthcare cost, quality, practicesAtherosclerosis20170 iqtibos

    ABIABI:AkademIndex/openalex/2017.article.000691

16. P767Efficacy and safety of switching simvastatin intolerant patients with coronary artery disease to rosuvastatin treatment

    Aleksandr B. Shek, Р. Д. Курбанов, G J Abdullaeva +3

    MaqolaLipoproteins and Cardiovascular HealthEuropean Heart Journal20170 iqtibos

    ABIABI:AkademIndex/openalex/2017.article.000751

17. A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost‑Effectiveness Analysis

    S. Djalalov, Jaclyn Beca, Emmanuel M. Ewara +1

    MaqolaHealth Systems, Economic Evaluations, Quality of LifePharmacoEconomics20190 iqtibos

    ABIABI:AkademIndex/openalex/2019.article.000160

18. PCN252 QUALITY EVALUATION OF PHARMACOECONOMIC STUDIES IN RUSSIAN CANCER RESEARCH: AN OUTSIDE VIEW

    S. Djalalov, Dilfuza Djalalova, Murray Krahn +2

    MaqolaHealth Systems, Economic Evaluations, Quality of LifeValue in Health20190 iqtibos

    ABIABI:AkademIndex/openalex/2019.article.001253

19. Improving clinical practice in primary care for the prevention and control of noncommunicable diseases: a multi-actor approach to two regional pilot projects in Kazakhstan

    Erica Barbazza, Saltanat Yegeubayeva, Baktygul Akkazieva +3

    Sharh maqolaGlobal Public Health Policies and EpidemiologyCardiovascular Diagnosis and Therapy20190 iqtibos

    ABIABI:AkademIndex/openalex/2019.review-article.000011

20. Review of Pharmacoeconomic Studies in Russian Cancer Research: An Outside View

    S. Djalalov, Dilfuza Djalalova, Murray Krahn +2

    Sharh maqolaHealth Systems, Economic Evaluations, Quality of LifeValue in Health Regional Issues20190 iqtibos

    ABIABI:AkademIndex/openalex/2019.review-article.000012

21. Study of clinical efficiency and portability of the Pramipexol BIO product

    S. Musaev, Y. Musaeva, S. Xakimova

    MaqolaParkinson's Disease Mechanisms and TreatmentsParkinsonism & Related Disorders20200 iqtibos

    ABIABI:AkademIndex/openalex/2020.article.003856

22. Assessment of depressive conditions in Parkinson's disease (PD) and the impact on the quality of life of patients

    A. Ismatov, D. Tolibov, М М Махмудов

    MaqolaParkinson's Disease Mechanisms and TreatmentsParkinsonism & Related Disorders20200 iqtibos

    ABIABI:AkademIndex/openalex/2020.article.003952

23. Evaluation of the effectiveness and competitiveness of scientific and innovative activities of medical research organizations and medical universities

    Vitaliy Koikov, A Umbetzhanova, Amangali Akanov +3

    MaqolaHealth and Medical Research ImpactsJournal of Health Development20200 iqtibos

    ABIABI:AkademIndex/openalex/2020.article.005097

24. Reinforcing Adherence to Lipid-lowering Therapy after an Acute Coronary Syndrome: A Pragmatic Randomized Controlled Trial

    Stefanos Zafeiropoulos, Ioannis T. Farmakis, Αναστάσιος Κάρτας +6

    PreprintLipoproteins and Cardiovascular HealthResearch Square20200 iqtibos

    ABIABI:AkademIndex/openalex/2020.preprint.000048

25. Reinforcing Adherence to Lipid-lowering Therapy after an Acute Coronary Syndrome: A Pragmatic Randomized Controlled Trial

    Stefanos Zafeiropoulos, Ioannis T. Farmakis, George Giannakoulas +1

    PreprintLipoproteins and Cardiovascular HealthResearch Square20200 iqtibos

    ABIABI:AkademIndex/openalex/2020.preprint.000099